Accendra Health (ACH) Common Equity (2009 - 2026)

Accendra Health (ACH) has 18 years of Common Equity data on file, last reported at -$464.8 million in Q1 2026.

• On a quarterly basis, Common Equity fell 181.4% year-over-year to -$464.8 million in Q1 2026; TTM through Mar 2026 was -$464.8 million, a 181.4% decrease from a year earlier, with the FY2025 full-year figure at -$461.0 million, down 178.62% from the prior year.
• Common Equity for Q1 2026 stood at -$464.8 million, down from -$461.0 million in the prior quarter.
• Over the last five years, Common Equity for ACH reached as high as $966.8 million in Q3 2022 and fell as low as -$464.8 million in Q1 2026.
• Historically, Common Equity has averaged $571.0 million across 5 years, with a median of $895.7 million in 2024.
• Across the five-year window, Common Equity grew 20.52% in 2022 and tumbled 181.4% in 2026, its largest moves.
• Year by year, Common Equity stood at $966.7 million in 2022, then decreased by 2.22% to $945.3 million in 2023, then slumped by 37.97% to $586.4 million in 2024, then sank by 178.62% to -$461.0 million in 2025, then retreated by 0.82% to -$464.8 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$464.8 million in Q1 2026, -$461.0 million in Q4 2025, and -$429.5 million in Q3 2025.